Clinical Trials

GastrointestinalHead & Neck

250 enrolled

Esophageal Neoplasms, Anastomotic Leak, Recurrent Laryngeal Nerve Injuries

NCT06341985 2024-04-02

DORIAN

180 enrolled

Head and Neck Neoplasms

NCT06342739 2024-04-02

Verbal Synchrony, Satisfaction and Decision-making in Face-to-face Consultations

60 enrolled

Thyroid Nodule

NCT05400239 2024-03-21

SOTO: Treatment Sensitivity of Organoids to Predict Treatment Outcome

60 enrolled

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT06321640 2024-03-20

POSITive

BreastDermatologicGastrointestinalGenitourinaryHead & NeckThoracic

265 enrolled

Breast Neoplasms, Carcinoma, Transitional Cell, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Colorectal Neoplasms

NCT03024489 2024-03-15

Palbociclib With Cetuximab and IMRT for Locally Advanced Squamous Cell Carcinoma

Phase 1/2 Unknown

27 enrolled

Head and Neck Neoplasms

NCT04354324 2024-03-15

Treatment Efficacy and Safety of Low-dose Radioiodine Ablation for Intermediate-risk Differentiated Thyroid Carcinoma

254 enrolled

EndocrineHead & Neck

Thyroid Cancer, Papillary

NCT06308796 2024-03-15

RADIOCARIES

40 enrolled

Dental Caries, Head and Neck Neoplasms

NCT06308016 2024-03-13

Study of the Risk of Pharyngocutaneous Fistula in a Population of Patients Undergoing Total Laryngectomy and Creation of a Score for Pre-operative Risk Stratification.

500 enrolled

Phase EARLY_PHASE1 Unknown

Laryngeal Neoplasms

NCT06097793 2024-03-12

KSD-101 Therapy for EBV-associated Nasopharyngeal Carcinoma: an Exploratory Clinical Trial

12 enrolled

Nasopharyngeal Carcinoma

NCT04858100 2024-03-07

Oral Potentially Malignant Disorders: Comparison Between Surgical Treatment and Wait and See Approach

310 enrolled

Leukoplakia, Oral, Mouth Neoplasms

NCT05011227 2024-03-06

Camrelizumab and Chemotherapy Combined With Endoscopic Surgery for Recurrent Nasopharyngeal Carcinoma

100 enrolled

Nasopharyngeal Carcinoma

NCT05156177 2024-03-05

COMRAD-HNSCC

40 enrolled

Squamous Cell Carcinoma of Head and Neck

NCT02489084 2024-03-01

HANS

2,000 enrolled

Head and Neck Neoplasms

NCT06133790 2024-02-29

HPVNGS

60 enrolled

Head and Neck Neoplasms

NCT06287034 2024-02-29

The Role of the Free/Pedunculated Flap in Total Laryngectomy After (Chemo-)Radiotherapy Failure for Laryngeal Carcinoma: Impact on the Risk of Pharyngocutaneous Fistula (PCF)

102 enrolled

Laryngeal Neoplasms

NCT05942794 2024-02-28

Identification of Oral Lesions Through an Autofluorescence System

200 enrolled

DermatologicHead & Neck

Carcinoma, Squamous Cell, Keratosis, Leukoplakia, Oral, Lichen Planus, Mouth Diseases, Mouth Neoplasms, Lichen Planus, Oral

NCT04040673 2024-02-26

RAFTER

40 enrolled

Neoplasms, Thyroid Diseases, Thyroid Neoplasms

NCT05482841 2024-02-26

LUSENT

80 enrolled

Head and Neck Neoplasms

NCT06272617 2024-02-22

Acupuncture for Prevention and Treatment of Oral-related Complications Caused by Radiotherapy for Head and Neck Cancer

138 enrolled

Head and Neck Neoplasms

NCT04671862 2024-02-21

Photobiomodulation for the Prevention of Radiation Induced Oral Mucositis

25 enrolled

Head and Neck Neoplasms, Radiodermatitis, Stomatitis

NCT06256809 2024-02-21

QQA-FPD-PMML

160 enrolled

Leukoplakia, Oral

NCT06269731 2024-02-21

Anxiety & Depression in Thyroid Cancer Patients

159 enrolled

Anxiety Disorders, Depression, Thyroid Neoplasms

NCT05860335 2024-02-20

Efficacy and Safety of Toripalimab Combined With AP-induced Chemotherapy Followed in Non-metastatic IVB Hypopharyngeal Cancer

30 enrolled

Hypopharyngeal Neoplasms

NCT06154863 2024-02-20

Recurrence in Patients With Differentiated Thyroid Cancer

100 enrolled

EndocrineHead & Neck

Differentiated Thyroid Cancer

NCT03924466 2024-02-16

VUBAR

BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

55 enrolled

Biliary Tract Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Pancreatic Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Stomach Neoplasms, Uterine Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

NCT06257121 2024-02-13

CRISP

15 enrolled

Claustrophobia, Anxiety Disorders, Head and Neck Neoplasms

NCT01819480 2024-02-09

Efficacy and Safety of TORS for SCCA

110 enrolled

Squamous Cell Carcinoma of Head and Neck, Carcinoma

NCT05893810 2024-02-08

Bacterial Decolonization to Prevent Radiation-induced Oral Mucositis

Phase 3 Unknown

176 enrolled

Nasopharyngeal Carcinoma

NCT05385926 2024-02-05

Combining RT With Immunotherapy and Chemotherapy in Metastatic Nasopharyngeal Carcinoma

34 enrolled

Nasopharyngeal Neoplasms

NCT06241092 2024-02-05

AI-Based Multimodal Multi-tasks Analysis Reveals Tumor Molecular Heterogeneity, Predicts Preoperative Lymph Node Metastasis and Prognosis in Papillary Thyroid Carcinoma

256 enrolled

EndocrineHead & Neck

Thyroid Cancer, Papillary, Lymphatic Metastasis

NCT06235918 2024-02-01

Neoadjuvant Tislelizumab Plus Chemotherapy for Resectable Locally-advanced Head and Neck Squamous Cell Carcinoma

30 enrolled

BreastHead & NeckLymphoid

Squamous Cell Carcinoma of Head and Neck

NCT03789097 2024-01-30

Vaccination With Flt3L, Radiation, and Poly-ICLC

Phase 1/2 Unknown

56 enrolled

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Carcinoma, Lymphoma, Lymphoma, Non-Hodgkin

NCT06224166 2024-01-26

Analysis of HPV and Biomarkers Present in the Biological Fluids of Patients Suffering From Head and Neck Cancer as a Non-invasive Strategy for Detecting Recurrence

283 enrolled

Head and Neck Neoplasms

NCT06227039 2024-01-26

PARVA

80 enrolled

Laryngeal Neoplasms, Vocal Cord Paralysis, Acute Pain

NCT03532737 2024-01-23

Concomitant Immune Check Point Inhibitor With Radiochemotherapy in Head And Neck Cancer

50 enrolled

Head and Neck Neoplasms

NCT03146650 2024-01-18

Nivolumab and Ipilimumab in Treating Patients With Metastatic/Recurrent ACC of All Sites and Non-ACC Salivary Gland Cancer

25 enrolled 14 charts

Salivary Gland Neoplasms

NCT03708822 2024-01-18

Study of Docetaxel and Cisplatin Combined With Nimotuzumab As First-Line Treatment in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma

48 enrolled

Nasopharyngeal Carcinoma

NCT06201039 2024-01-11

CLAWED

80 enrolled